<?xml version="1.0" encoding="UTF-8"?>
<ref id="B97-jcm-09-01917">
 <label>97.</label>
 <element-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>Baron</surname>
    <given-names>S.A.</given-names>
   </name>
   <name>
    <surname>Devaux</surname>
    <given-names>C.</given-names>
   </name>
   <name>
    <surname>Colson</surname>
    <given-names>P.</given-names>
   </name>
   <name>
    <surname>Raoult</surname>
    <given-names>D.</given-names>
   </name>
   <name>
    <surname>Rolain</surname>
    <given-names>J.-M.</given-names>
   </name>
  </person-group>
  <article-title>Teicoplanin: An alternative drug for the treatment of coronavirus COVID-19?</article-title>
  <source>Int. J. Antimicrob. Agents</source>
  <year>2020</year>
  <fpage>105944</fpage>
  <pub-id pub-id-type="doi">10.1016/j.ijantimicag.2020.105944</pub-id>
  <pub-id pub-id-type="pmid">32179150</pub-id>
 </element-citation>
</ref>
